Saltlick is a National-Scale AI-Enabled Cancer Preventive Platform.
A Public-Private Partnership Model for Early Risk Assessment & Cancer Prevention
Designed to Support Government Cancer Control Goals under NPCDCS, NHM & PM-JAY, delivering measurable impact at scale under a public-private partnership
Traditional healthcare systems focus on treatment after the disease appears. Salt Lick changes the paradigm by identifying high-risk individuals before symptomatic cancer develops.
Through AI-powered predictive analytics, community screening infrastructure, and integrated referral systems, Salt Lick aims to significantly improve late-stage cancer detection and survival outcomes.
Salt Lick Healthcare Pvt Ltd, headquartered in Mumbai, is a proud Esperer group company dedicated to transformative cancer care. As a true Indian innovation powerhouse supported by the Government of India, this successful startup has earned global recognition through its pioneering cancer nutrition solutions, backed by multiple international patents.
Adding to its excellence, Salt Lick Healthcare has developed an AI-enabled cancer risk assessment facility tailored for the Indian population, enabling early detection and personalised prevention strategies rooted in local demographics and genetics.
Salt Lick Healthcare stands as a shining symbol of Indian ingenuity, upholding the nation’s pride in innovation on the world stage.
Meet the Team
Salt Lick Healthcare Pvt Ltd, headquartered in Mumbai, is a proud Esperer group company dedicated to transformative cancer care. As a true Indian innovation powerhouse supported by the Government of India, this successful startup has earned global recognition through its pioneering cancer nutrition solutions, backed by multiple international patents.
Founder
Dr. Raktim Chattopadhyay
A distinguished cancer researcher with a PhD in Cancer Biology, Dr Chattopadhyay has made significant contributions to the field, notably through his groundbreaking work on the gut microbiota-cancer relationship via the DiNI Axis. His research, backed by global patents and peer-reviewed publications, focuses on molecular nutrition, precision oncology, and translational interventions that enhance patient outcomes alongside conventional therapies.
As a serial entrepreneur, he has successfully built multiple ventures in oncology nutrition and biotechnology, including the Esperer Group. At SaltLick Healthcare, he integrates cutting-edge technology with evidence-based clinical solutions to make advanced diagnostics, supportive care, and holistic cancer management more accessible and scalable, especially in emerging markets.
Driven by a patient-centric vision, Dr Chattopadhyay continues to bridge rigorous academic research, innovation, and compassionate care to transform oncology globally.
CEO
Mr. Himanshu Dave
Strategic Healthcare Leader with over 35 years across pharmaceuticals and public health systems.
Architect of scalable healthcare delivery models integrating private-sector innovation with public health priorities.
Led the creation of India’s largest rural free-dialysis network, expanding lifesaving access to nearly one-third of the nation’s population.
​
Leadership Footprint:
Wockhardt | Astellas | Fairfax Financial Holdings (Foundation)